Calif. High Court To Review Novartis Generic Drug Suit
The California Supreme Court will review a state appeals court's March decision that brand-name drugmaker Novartis could be held liable for negligent misrepresentation and failure to warn of the alleged dangers...To view the full article, register now.
Already a subscriber? Click here to view full article